Anadys Forms Collaboration With Gilead

gilead, Inc. and Gilead Sciences, Inc. have entered into a collaboration to discover novel antiviral compounds.

As part of the collaboration agreement, Anadys will design, configure and run uHTS-ATLAS screens against a key viral target selected by Gilead.

This agreement leverages Anadys’ powerful ability to screen for small molecules that bind to proteins that are difficult to screen using conventional methods.

Under the terms of the agreement, Anadys will design and run uHTS-ATLAS assays against Gilead’s compound collection.

Gilead will have exclusive rights to develop and commercialize any products resulting from compounds discovered in the collaboration.

“We are very pleased to collaborate with Gilead on this important and challenging viral target,” said Dr. Steve Worland, Chief Scientific Officer of Anadys.

“Gilead is viewed as one of the premier organizations involved in antiviral research, and their decision to employ uHTS- ATLAS is important validation for our technology. It also highlights one of the key advantages of our technology in that we can screen targets that have traditionally been a challenge.”

“The collaboration with Gilead further illustrates Anadys’ overall commitment to broadening our efforts in the antiviral therapeutic area,” said Michael Kamdar, Vice President of Corporate Development and Strategy for Anadys.

“We look forward to building a long term relationship with Gilead, which has a strong record of developing and commercializing antiviral therapies.” Anadys Pharmaceuticals, Inc. is a new generation drug discovery company committed to applying an integrated approach that combines biology and chemistry to develop new small molecule therapeutics.

Gilead Sciences is a biopharmaceutical company has five marketed products and focuses its research and clinical programs on anti-infectives, including antivirals, antifungals and antibacterials.


Generic drug giant Dragon Pharma is offering:

Order Dragon Pharma Labs on the Internet

Cypionat 250 - Bulk Price

Administration: Injection
Primary Substance: Testosterone Cypionate
Branded by: Dragon Pharma LLC
Pack: 10 x 10 mL vial (250 mg/mL)
Price: 10 x $36.00

Clenbuterol - Bulk Price

Administration: Oral
Main Substance: Clenbuterol Hydrochloride
Producer: Dragon Pharma Labs
Package: 10 x 100 pastilles (40 mcg/tab)
Price: 10 x $25.00

Clenbuterol - Discount Price

Administration: Oral
Principal Substance: Clenbuterol Hydrochloride
Manufacturer: Dragon Pharma LLC
Unit: 30 x 100 tablets (40 mcg/pastille)
Price: 30 x $20

Turanabol - Bulk Price

Administration: Oral
Principal Component: Chlorodehydromethyltestosterone
Manufacturer: Dragon Pharmaceuticals
Unit: 10 x 100 tablets (10 mg/pastille)
Price: 10 x $70.00

Deca 300

Injectable Anabolic Steroid
Basic Chemical Name: Nandrolone Decanoate
Produced by: Dragon Pharma LLC
Package: 1 X 10 ml (300 mg/ml)

Winstrol Depot

Injectable Anabolic Steroid
Prime Ingredient: Stanozolol
Manufacturer: Dragon Pharma LLC
Amount: 1 X 10 ml (50 mg/ml)

EQ 300 - Discount Price

Administration: Injection
Prime Constituent: Boldenone Undecylenate
Producer: Dragon Pharmaceuticals
Unit: 30 x 10 mL vial (300 mg/mL)
Price: 30 x $29.00

Winstrol Tabs

Synthetic Anabolic Steroidal Agent
Main Component: Stanozolol
Manufacturer: Dragon Pharmaceuticals
Pack: 1 X 100 pills (50 mg/tab)

Sustanon 350 - Bulk Price

Administration: Injection
Prime Constituent: Testosterone Blend
Manufacturer: Dragon Pharmaceuticals
Pack: 10 x 10 mL vial (350 mg/mL)
Price: 10 x $45.00

EQ 500

Injectable Anabolic Steroid
Prime Ingredient: Boldenone Undecylenate
Produced by: Dragon Pharma Labs
Pack: 1 X 10 ml (500 mg/ml)

EQ 300 [10 Vials]

Injectable Steroid for Muscle Growth
Principal Constituent: Boldenone Undecylenate
Producer: Dragon Pharma LLC
10 Vials [10 mL per Vial (300 mg/ml)]
Price: 10 x $42.00 = $420.00 in Total

Winstrol Depot

Injectable Anabolic Steroid
Base Component: Stanozolol
Produced by: Dragon Pharma
Package: 10 mL vial (50 mg/mL)